Latest Insights on LANC
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Investors’ Survival Guide to the Coronavirus January 31, 2020 American Investor Today, Diversified Investments The coronavirus is spreading fear through global markets. But there is one beaten-down sector that will emerge from the global crisis even stronger. Anthony Planas reveals the No. 1 fund that every investor should add to their portfolio today.
Virus Shakeouts and Earnings Breakouts; Boeing Defies Gravity January 29, 2020 2020 Financial Crisis, Great Stuff See No Virus, Hear No Virus, Speak No Virus Welcome to 2020, where the earnings reactions are made up … and the coronavirus doesn’t matter. That’s right, folks. The Wuhan coronavirus just passed 6,000 confirmed cases in mainland China — making it bigger and faster than SARS — and no one on Wall Street cares. […]
Scared Money Is Selling Oil — How to Profit in February January 29, 2020 American Investor Today, Commodities, Oil Fear around the spread of the coronavirus is pushing oil prices lower. But there are signs that oil will rebound. John Ross shares how to grab double-digit gains on oil’s rally by March.
2 Ways to Protect Yourself From This Little-Known Danger January 28, 2020 Big Picture. Big Profits., Currency, Gold, Wealth Protection [4-minute read] Everyone is focused on the coronavirus and ignoring this mousetrap.MEET OUR EXPERTS
Chief Strategist of Strategic Fortunes and three elite services
Director of VIP Services
Founder of Weekend Trader
Founder of TRADEMONSTER.ai
Research Analyst
Chief Investment Strategist of Money & Markets
